Madrigal Pharmaceuticals (MDGL) Goodwill & Intangibles (2016 - 2026)

Madrigal Pharmaceuticals (MDGL) has 4 years of Goodwill & Intangibles data on file, last reported at $7.3 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $7.3 million, up 57.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (up 57.02% YoY), and the FY2025 annual result was $7.4 million, up 56.08% from the prior year.
• Goodwill & Intangibles eased to $7.3 million in Q1 2026 per MDGL's latest filing, from $7.4 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $7.5 million in Q3 2025 and troughed at $4.5 million in Q2 2025.
• A 3-year average of $5.6 million and a median of $4.9 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles slipped 7.37% in 2025, then soared 57.02% in 2026.
• A 3-year view of Goodwill & Intangibles shows it stood at $4.7 million in 2024, then soared by 56.08% to $7.4 million in 2025, then decreased by 1.31% to $7.3 million in 2026.
• Business Quant data shows MDGL's Goodwill & Intangibles at $7.3 million in Q1 2026, $7.4 million in Q4 2025, and $7.5 million in Q3 2025.